ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

Sanofi Complete list of announcements declared & dividend announcements by Sanofi GCVRZ

Sanofi GCVRZ listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Sanofi GCVRZ

CD&R makes Rs 2,983 cr open offer for 26% stake in Sanofi Consumer Healthcare India
Global investment firm CD&R announces an open offer to acquire a 26% stake in Sanofi Consumer Healthcare India for up to Rs 2,983 crore. This follows exclusive negotiations to acquire a controlling stake in Opella. The offer price is Rs 4,982.05 per sh
Announcement as on 21 October 2024

Panacea Biotec, Sanofi settle patent infringement suit
Panacea Biotec has settled a patent infringement dispute with Sanofi Healthcare India regarding its fully liquid hexavalent vaccine, EasySix. Sanofi agreed not to launch its Shan6 vaccine in India and will withdraw oppositions against Panacea's patent amen
Announcement as on 17 September 2024

Panacea, Sanofi settle patent litigation over hexavalent vaccine
Panacea Biotec has settled a patent infringement case with Sanofi Healthcare India over a hexavalent vaccine. Sanofi will not launch its Shan6 vaccine in India and will withdraw its opposition to Panacea's patent. Panacea will forgo claims for damages. The
Announcement as on 17 September 2024

Sanofi Consumer Healthcare lists on stock exchanges after demerger, shares hit 5% upper circuit on day 1
Shares of Sanofi Consumer Healthcare India made their market debut on Friday, listing on both the NSE and BSE. On its first day of trading, the stock hit a 5% upper circuit limit, reaching Rs 4,702.9. Sanofi Consumer Healthcare India is the demerged consum
Announcement as on 13 September 2024

Sanofi gets drug regulator nod to market RSV therapy in India
French drugmaker Sanofi announced on Thursday that it has received approval from India's Central Drugs Standard Control Organization (CDSCO) to market its novel therapy, Beyfortus, in India. The therapy is aimed at protecting newborns and infants from resp
Announcement as on 01 August 2024

Announcements by Sanofi first page | Next page | Prev page |

GCVRZ Sanofi current price & indicator signals

Moving Averages for Sanofi

  • 5Day Average: 0.87
  • 12Day Average: 0.87
  • 20Day Average: 0.87
  • 50Day Average: 0.87
  • 100Day Average: 0.83
  • 150Day Average: 0.73
  • 200Day Average: 0.68

GCVRZ Indicators & signals

Indicator MACD (12,26,9)

0.84, 0.81, 0.05
Indicator MACD is in positive zone

Indicator ADX (14)

0, 28.57, 28.57
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 64
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GCVRZ Sanofi are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Tue Mar 2020 0.87 0.87 to 0.88 0% 18.75 times
02 Mon Mar 2020 0.87 0.87 to 0.87 0% 0.55 times
28 Fri Feb 2020 0.87 0.87 to 0.88 0% 1.5 times
27 Thu Feb 2020 0.87 0.87 to 0.88 0% 5.49 times
26 Wed Feb 2020 0.87 0.87 to 0.87 0% 0.2 times
25 Tue Feb 2020 0.87 0.87 to 0.87 0% 0.24 times
24 Mon Feb 2020 0.87 0.86 to 0.87 0% 0.57 times
21 Fri Feb 2020 0.87 0.87 to 0.87 0% 0.54 times
20 Thu Feb 2020 0.87 0.87 to 0.87 0% 0.09 times
19 Wed Feb 2020 0.87 0.87 to 0.87 0% 0.28 times
18 Tue Feb 2020 0.87 0.87 to 0.87 0% 0.54 times
17 Mon Feb 2020 0.87 0.87 to 0.87 0% 0 times

Videos related to: GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

 

Back to top